✦ LIBER ✦

A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor

✍ Scribed by Axel Bex; Henk Mallo; Martijn Kerst; John Haanen; Simon Horenblas; Gijsbert C. de Gast

Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 207 KB
Volume: 54
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-004-0630-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase-II study of combination of pegyl

A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer

✍ Kaisa Leea Sunela; Sanna Koskinen; Pirkko-Liisa Kellokumpu-Lehtinen 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 348 KB

Phase II study of lenalidomide in patien

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma

✍ Toni K. Choueiri; Robert Dreicer; Brian I. Rini; Paul Elson; Jorge A. Garcia; Sn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 1 views

Phase I and II trials of subcutaneously

Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma

✍ T. Olencki; D. Peereboom; L. Wood; G. T. Budd; A. Novick; J. Finke; D. McLain; P 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 103 KB

Phase II trial of 5-fluorouracil, interf

Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma

✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d

A Phase II trial of bryostatin-1 for pat

A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma

✍ Lance Pagliaro; Danai Daliani; Robert Amato; Shi-Ming Tu; Donnah Jones; Terry Sm 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

A Phase II trial of intravenous gemcitab

A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma

✍ Christopher W. Ryan; Nicholas J. Vogelzang; Walter M. Stadler 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to determine the response rate and toxicity of gemcitabine and continuous‐infusion 5‐fluorouracil (5‐FU) in combination with subcutaneous interleukin‐2 (IL2) and interferon‐α (IFNA) in patients with metastatic renal cell carcinoma. ## METH